Literature DB >> 30956889

Contextualizing and individualizing truth-telling about pain in a tough and unjust world.

Michael H Andreae1.   

Abstract

We consider recent research findings regarding patients' individual pain perception and phenotype, embodied in the altered neural network vulnerability, the result of connatal setup and acquired exposure, to question Dr. Gligorov's inferences. We contextualize Dr. Gligorov's discourse with concrete clinical cases embedded in obstetric anesthesia scenarios, where physicians may knowingly administer placebo pain medication and where truth-telling about pain has important immediate and long-term clinical consequences, in particular during subsequent repeated clinical encounters. Furthermore, truth-telling about pain implies acknowledging the social and economic context in which pain is treated, or more often not treated. In particular minorities and indigent populations are routinely undertreated for pain due to structural or individual bias driving cruel healthcare disparities. Finally, we argue that the patients' viewpoint is lacking in this debate at present but all stakeholders' perspective are important in the discussion of truth-telling about pain.

Entities:  

Year:  2018        PMID: 30956889      PMCID: PMC6447363          DOI: 10.1080/21507740.2018.1496167

Source DB:  PubMed          Journal:  AJOB Neurosci        ISSN: 2150-7759


  10 in total

1.  Epidemiologic analysis of racial/ethnic disparities: some fundamental issues and a cautionary example.

Authors:  Jay S Kaufman
Journal:  Soc Sci Med       Date:  2008-01-14       Impact factor: 4.634

Review 2.  Predicting, preventing and managing persistent pain after breast cancer surgery: the importance of psychosocial factors.

Authors:  Kristin L Schreiber; Henrik Kehlet; Inna Belfer; Robert R Edwards
Journal:  Pain Manag       Date:  2014

3.  A pragmatic trial to improve adherence with scheduled appointments in an inner-city pain clinic by human phone calls in the patient's preferred language.

Authors:  Michael H Andreae; Singh Nair; Jonah S Gabry; Ben Goodrich; Charles Hall; Naum Shaparin
Journal:  J Clin Anesth       Date:  2017-08-23       Impact factor: 9.452

4.  Stakeholders' Views on Barriers to Research on Controversial Controlled Substances.

Authors:  Evelyn Rhodes; Michael Andreae; Tyler Bourgiose; Debbie Indyk; Rosamond Rhodes; Henry Sacks
Journal:  J Clin Ethics       Date:  2016

Review 5.  Neuronal plasticity: increasing the gain in pain.

Authors:  C J Woolf; M W Salter
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

6.  The Effect of Initiatives to Overcome Language Barriers and Improve Attendance: A Cross-Sectional Analysis of Adherence in an Inner City Chronic Pain Clinic.

Authors:  Michael H Andreae; Robert S White; Kelly Yan Chen; Singh Nair; Charles Hall; Naum Shaparin
Journal:  Pain Med       Date:  2017-02-01       Impact factor: 3.750

7.  Antiemetic Prophylaxis as a Marker of Health Care Disparities in the National Anesthesia Clinical Outcomes Registry.

Authors:  Michael H Andreae; Jonah S Gabry; Ben Goodrich; Robert S White; Charles Hall
Journal:  Anesth Analg       Date:  2018-02       Impact factor: 5.108

8.  Birth trauma: in the eye of the beholder.

Authors:  Cheryl Tatano Beck
Journal:  Nurs Res       Date:  2004 Jan-Feb       Impact factor: 2.381

9.  A longitudinal linear model of patient characteristics to predict failure to attend an inner-city chronic pain clinic.

Authors:  Naum Shaparin; Robert White; Michael Andreae; Charles Hall; Andrew Kaufman
Journal:  J Pain       Date:  2014-04-18       Impact factor: 5.820

10.  Long-term Functional Outcomes after Regional Anesthesia: A Summary of the Published Evidence and a Recent Cochrane Review.

Authors:  Arthur Atchabahian; Michael Andreae
Journal:  Refresh Courses Anesthesiol       Date:  2015
  10 in total
  1 in total

1.  Medicaid insurance status predicts postoperative mortality after total knee arthroplasty in state inpatient databases.

Authors:  Stephan R Maman; Michael H Andreae; Licia K Gaber-Baylis; Zachary A Turnbull; Robert S White
Journal:  J Comp Eff Res       Date:  2019-10-23       Impact factor: 1.744

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.